| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |